What are the equivalents to Valium (diazepam) and Ativan (lorazepam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benzodiazepine Equivalence: Diazepam and Lorazepam

For benzodiazepine equivalence, 10 mg of diazepam (Valium) is approximately equivalent to 2-2.5 mg of lorazepam (Ativan), with important clinical differences in their pharmacokinetics and applications.

Potency and Equivalence

  • Lorazepam is approximately 4-5 times more potent than diazepam 1
  • Standard equivalence:
    • 10 mg diazepam = 2-2.5 mg lorazepam 1

Key Pharmacokinetic Differences

Absorption

  • Diazepam: Better absorbed orally than intramuscularly
  • Lorazepam: Similar absorption via both oral and intramuscular routes 1

Onset and Duration

  • Diazepam: More rapid onset but shorter duration
  • Lorazepam: Slower onset but significantly longer duration of action 1, 2

Distribution and Metabolism

  • Diazepam:

    • Longer elimination half-life (average 51.2 hours)
    • Higher lipid solubility
    • Larger volume of distribution (133 L/kg for unbound drug)
    • Has active metabolites
  • Lorazepam:

    • Shorter elimination half-life (average 15.7 hours)
    • Lower lipid solubility
    • Smaller volume of distribution (12 L/kg for unbound drug)
    • No active metabolites 2

Clinical Applications and Preferences

Status Epilepticus

  • If IV access is available, both lorazepam and diazepam are effective
  • Lorazepam is preferred over diazepam for status epilepticus due to:
    • Longer duration of anticonvulsant activity
    • Lower need for additional doses
    • Lower incidence of respiratory depression 3, 4, 5

Hepatic Dysfunction

  • Lorazepam is preferred in patients with:
    • Hepatic dysfunction
    • Advanced age
    • Serious medical comorbidities
    • This is due to its metabolism primarily through glucuronide conjugation rather than hepatic pathways 6

Safety Considerations

Respiratory Depression

  • Both medications can cause respiratory depression, especially when combined with other CNS depressants
  • Lorazepam shows lower rates of respiratory depression (4.4%) compared to diazepam (5.6%) in status epilepticus treatment 4

Venous Complications

  • Lorazepam IV administration is associated with fewer venous thrombosis complications compared to diazepam 1

Dependence and Withdrawal

  • Both medications carry risks of:
    • Abuse, misuse, and addiction
    • Physical dependence with prolonged use
    • Withdrawal symptoms with abrupt discontinuation
    • Duration of use should ideally be limited to 4 weeks maximum 6, 7

Important Cautions

  • Never abruptly discontinue either medication after prolonged use; implement a gradual taper over 2-12 weeks
  • Avoid concurrent use with opioids, alcohol, or other CNS depressants due to increased risk of severe respiratory depression and death
  • Elderly patients have heightened sensitivity to all benzodiazepine effects and require lower dosing
  • Monitor for paradoxical reactions including increased anxiety, agitation, and irritability 6, 7

By understanding these equivalence relationships and clinical differences between diazepam and lorazepam, clinicians can make more informed decisions when selecting the appropriate benzodiazepine for specific clinical scenarios.

References

Research

Comparison of the actions of diazepam and lorazepam.

British journal of anaesthesia, 1979

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: a randomized controlled trial.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2010

Guideline

Medication Management and Safety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.